{"id":1987,"date":"2025-10-08T17:01:15","date_gmt":"2025-10-08T22:01:15","guid":{"rendered":"https:\/\/certification.osteopathic.org\/addiction-medicine\/?page_id=1987"},"modified":"2025-10-10T13:16:34","modified_gmt":"2025-10-10T18:16:34","slug":"addiction-medicine-2026-longitudinal-assessment-references","status":"publish","type":"page","link":"https:\/\/certification.osteopathic.org\/addiction-medicine\/home\/addiction-medicine-2026-longitudinal-assessment-references\/","title":{"rendered":"Addiction Medicine 2026 Longitudinal Assessment References"},"content":{"rendered":"<h2><strong>Addiction Medicine 2026 Longitudinal Assessment References<\/strong><\/h2>\n<p>Due to copyright restrictions, the Addiction Medicine Conjoint Committee cannot provide most reference materials used for longitudinal assessment. However, a list of references used for the 2026 longitudinal assessment can be found below.<\/p>\n<ul>\n<li>The ASAM Essentials of Addiction Medicine, 3rd ed. (2020); Ch. 42<\/li>\n<li>American Family Physician (Jan 2019); Vol. 99, Issue 1; Urine drug tests: ordering and interpreting results; pg. 33-39<\/li>\n<li>StatPearls (Feb 2025); Anabolic steroids The EMBO Journal (Feb 2000); Vol. 19, Issue 3; FHL2, a novel tissue-specific coactivator of the androgen receptor; pg. 359-369<br \/>\n<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482418\/\" target=\"_blank\" rel=\"noopener\">www.ncbi.nlm.nih.gov\/books\/NBK482418\/<\/a><\/li>\n<li>Centers for Disease Control and Prevention (Updated Mar 2024); Clinician brief: drug diversion<br \/>\n<a href=\"http:\/\/www.cdc.gov\/injection-safety\/hcp\/clinical-overview\/index.html\" target=\"_blank\" rel=\"noopener\">www.cdc.gov\/injection-safety\/hcp\/clinical-overview\/index.html<\/a><\/li>\n<li>Pharmacists described discomfort with naloxone, and uncertainties regarding billing insurance. International Journal of Drug Policy (Oct 2019); Barriers to naloxone use and acceptance among opioid users, first responders, and emergency department providers in New Hampshire, USA<br \/>\n<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7153573\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7153573\/<\/a><\/li>\n<li>Substance Abuse and Mental Health Services Administration (Updated Nov 2024); Statutes, regulations, and guidelines<br \/>\n<a href=\"http:\/\/www.samhsa.gov\/substance-use\/treatment\/statutes-regulations-guidelines\" target=\"_blank\" rel=\"noopener\">www.samhsa.gov\/substance-use\/treatment\/statutes-regulations-guidelines<\/a><\/li>\n<li>Substance Abuse and Mental Health Services Administration (May 2018); SAMHSA Disaster Technical Assistance Center Supplemental Research Bulletin: First responders: behavioral health concerns, emergency response, and trauma<br \/>\n<a href=\"http:\/\/www.samhsa.gov\/sites\/default\/files\/dtac\/supplementalresearchbulletin-firstresponders-may2018.pdf\" target=\"_blank\" rel=\"noopener\">www.samhsa.gov\/sites\/default\/files\/dtac\/supplementalresearchbulletin-firstresponders-may2018.pdf<\/a><\/li>\n<li>The ASAM Essentials of Addiction Medicine, 3rd ed. (2020); pg. 623 | StatPearls (Updated Jul 2023); Physiology, opioid receptor<br \/>\n<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK546642\/\" target=\"_blank\" rel=\"noopener\">www.ncbi.nlm.nih.gov\/books\/NBK546642\/<\/a><\/li>\n<li>The ASAM Principles of Addiction Medicine, 7th ed. (2024); Ch. 101; pg. 1570<br \/>\n<a href=\"https:\/\/monitoringthefuture.org\/wp-content\/uploads\/2023\/01\/mtfoverview2022.pdf\" target=\"_blank\" rel=\"noopener\">https:\/\/monitoringthefuture.org\/wp-content\/uploads\/2023\/01\/mtfoverview2022.pdf<\/a><\/li>\n<li>Monitoring the Future: National Survey Results on Drug Use 1975-2022 (Jan 2023); 2022 overview: key findings on adolescent drug use<\/li>\n<li>StatPearls (Updated Jun 2023); Dextromethorphan toxicity The ASAM Principles of Addiction Medicine, 6th ed. (2018); Ch. 17<br \/>\n<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538502\/\" target=\"_blank\" rel=\"noopener\">www.ncbi.nlm.nih.gov\/books\/NBK538502\/<\/a><\/li>\n<li>The ASAM Principles of Addiction Medicine, 6th ed. (2019); pg. 784-785<\/li>\n<li>National Institute on Drug Abuse (Updated July 2020); Substance use in older adults DrugFacts<br \/>\n<a href=\"https:\/\/nida.nih.gov\/publications\/drugfacts\/substance-use-in-older-adults-drugfacts\" target=\"_blank\" rel=\"noopener\">https:\/\/nida.nih.gov\/publications\/drugfacts\/substance-use-in-older-adults-drugfacts<\/a><\/li>\n<li>National Institute on Drug Abuse (Updated Sep 2024); Co-occurring disorders and health conditions<br \/>\n<a href=\"https:\/\/nida.nih.gov\/research-topics\/co-occurring-disorders-health-conditions\" target=\"_blank\" rel=\"noopener\">https:\/\/nida.nih.gov\/research-topics\/co-occurring-disorders-health-conditions<\/a><\/li>\n<li>Alcohol and Alcoholism (Oct 2020); Vol. 55, Issue 6; Alcoholics Anonymous and 12-step facilitation treatments for alcohol use disorder: a distillation of a 2020 Cochrane review for clinicians and policy makers; pg. 641-651<\/li>\n<li>National Institute on Alcohol Abuse and Alcoholism (Updated Dec 1996); NIAAA reports Project MATCH main findings<br \/>\n<a href=\"https:\/\/www.niaaa.nih.gov\/news-events\/news-releases\/niaaa-reports-project-match-main-findings\" target=\"_blank\" rel=\"noopener\">https:\/\/www.niaaa.nih.gov\/news-events\/news-releases\/niaaa-reports-project-match-main-findings<\/a><\/li>\n<li>Recovery Research Institute (Updated 2025); Twelve-step facilitation<br \/>\n<a href=\"https:\/\/www.recoveryanswers.org\/resource\/twelve-step-facilitation-tsf\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.recoveryanswers.org\/resource\/twelve-step-facilitation-tsf\/<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Addiction Medicine 2026 Longitudinal Assessment References Due to copyright restrictions, the Addiction Medicine Conjoint Committee cannot provide most reference materials used for longitudinal assessment. However, a list of references used for the 2026 longitudinal assessment can be found below. The ASAM Essentials of Addiction Medicine, 3rd ed. (2020); Ch. 42 American Family Physician (Jan 2019); &hellip; <a href=\"https:\/\/certification.osteopathic.org\/addiction-medicine\/home\/addiction-medicine-2026-longitudinal-assessment-references\/\">Continued<\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"parent":260,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"yst_prominent_words":[],"class_list":["post-1987","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/certification.osteopathic.org\/addiction-medicine\/wp-json\/wp\/v2\/pages\/1987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/certification.osteopathic.org\/addiction-medicine\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/certification.osteopathic.org\/addiction-medicine\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/certification.osteopathic.org\/addiction-medicine\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/certification.osteopathic.org\/addiction-medicine\/wp-json\/wp\/v2\/comments?post=1987"}],"version-history":[{"count":0,"href":"https:\/\/certification.osteopathic.org\/addiction-medicine\/wp-json\/wp\/v2\/pages\/1987\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/certification.osteopathic.org\/addiction-medicine\/wp-json\/wp\/v2\/pages\/260"}],"wp:attachment":[{"href":"https:\/\/certification.osteopathic.org\/addiction-medicine\/wp-json\/wp\/v2\/media?parent=1987"}],"wp:term":[{"taxonomy":"yst_prominent_words","embeddable":true,"href":"https:\/\/certification.osteopathic.org\/addiction-medicine\/wp-json\/wp\/v2\/yst_prominent_words?post=1987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}